Published in Vaccine Weekly, September 19th, 2001
If combined with the CT or LT R192G mucosal adjuvant, GTF vaccine facilitated mucosal and systemic immunity to S. mutans glucosyltransferase, reported D.J. Smith and colleagues at the Forsyth Institute, Boston.
"Synthetic peptide vaccines which are derived from functional domains of S. mutans GTF have been shown to induce protective immunity in Sprague-Dawley rats...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.